皮下用阿米万单抗在复发性或转移性头颈癌中展现出45%的令人鼓舞的总体反应率,中位持续时间为7.2个月
皮下用阿米万单抗在复发性或转移性头颈癌中展现出45%的令人鼓舞的总体反应率,中位持续时间为7.2个月
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.